Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 01 Oct 2026. About · Disclosures
Invesco India Pharma and Healthcare Fund - Regular Plan - Growth
Pharma & Health CareRegularGrowth
NAV
₹9.55
As on 01 Oct 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | -4.50% | — | — |
| 3 year | -4.50% | — | — |
| 5 year | -4.50% | — | — |
Returns
From NAVs through 01 Oct 2026
1Y
-4.50%
Total
3Y
-4.50%
p.a.
5Y
-4.50%
p.a.
SI
-4.50%
p.a.
Calendar years
-4.50%2026 YTD
Fund facts
StructureOpen Ended Scheme
ISININF205KA1BU1
SIP illustration
Rate
-4.50%
Invested
₹6,00,000
Illustrated
₹4,82,067
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
FAQ
What is Invesco India Pharma and Healthcare Fund - Regular Plan - Growth NAV today?
- The latest NAV of Invesco India Pharma and Healthcare Fund - Regular Plan - Growth is ₹9.55 as on 01 Oct 2026.
How has Invesco India Pharma and Healthcare Fund - Regular Plan - Growth performed vs its category?
- 1-year return -4.50%. Past performance does not guarantee future returns.
What are the returns of Invesco India Pharma and Healthcare Fund - Regular Plan - Growth?
- Trailing returns from published NAVs: 1 year -4.50%, 3 year -4.50% a year, 5 year -4.50% a year, since our first NAV -4.50% a year. Past performance does not guarantee future returns.
How would a SIP in Invesco India Pharma and Healthcare Fund - Regular Plan - Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of -4.50%. It is not a forecast.
What is the ISIN of Invesco India Pharma and Healthcare Fund - Regular Plan - Growth?
- The ISIN for Invesco India Pharma and Healthcare Fund - Regular Plan - Growth is INF205KA1BU1.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.
